Key complement-based drug developers have informed us that one of the most pressing problems in this rapidly growing field is that service providers lack knowledge and experience of the industry, forcing developers to use time and resources on work that they would rather outsource.
This summit will allow sponsors to gain a deep understanding of the most pressing concerns that the industry-leading developers have with CROs, CMOs and Assay Service Providers/Vendors, and strategies for how these could be overcome. Partnering with us will enable you to meet with high-level representatives from a range of companies, hear exactly what criteria they use to select vendors, and act on these insights to offer highly tailored products and services for complement therapeutics.
This is an unparalleled opportunity to demonstrate that you have the desire and capability to meet the increasing demands of this emerging field and cement your position as the industry leader.
If you have a product or service that will benefit this audience, please contact Jonathan Kilby-Phillips
Phone: +44 (0)20 31418700
Alternatively, you can register your interest below:
Discover the anticipated audience breakdown, feedback from previous partners of Cell & Viral Immunotherapies Series events and why you should partner with this industry-specific Complement-based Drug Development Summit Europe meeting.